Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3+
SponsorStanford University

About this trial

The goal of this study is to study the incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales, binned by week. Collect data on all interventions and assessments performed during the recovery post surgery up to 30 days, to understand what factors might cause Transient Neurologic Events (TNEs) and determine how these can be reduced in Moyamoya subjects post surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Moyamoya Disease (MMD) patients undergoing direct extracranial-intracranial (ECIC) bypass. Patients above the age of 3 years old are eligible for the study

Disqualifiers

Renal dysfunction, electrolyte disturbances neuromuscular disorders including Myaesthenia Gravis, heart block

Trial population

Moyamoya subject undergoing a standard of care direct and indirect extracranial-intracranial (ECIC) bypass.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Standard of Care

    Other intervention

    Standard of care treatment of Transient Neurologic Events (TNEs) as needed

Treatment groups

88 Participants
are divided into 1 treatment group
Group A: MoyaMoya Subjects1 intervention

Trial outcomes

Primary outcomes

1

Transient Neurologic Events (TNEs)

Number of Incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales (e.g., NIH Stroke Scale, Modified Rankin Scale), binned by week.

Time frame
30 days post-surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.